Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 5:57 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 43 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Electrophysiology Study Clear all

Conditions: Aging
Interventions: Gait Adaptation Training, Basic Physical Training; Behavioral
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years to 80 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Newark, New Jersey

Conditions: Congenital Disorders
Interventions: Not listed
Lead sponsor: Children's Healthcare of Atlanta; Other
Eligibility: Up to 21 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2002
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Cardiac Catheterization, Electrophysiology Procedure, Pediatric Cardiology
Interventions: Standard of Care, Weighted blanket; Other · Device
Lead sponsor: University of Michigan; Other
Eligibility: 3 Years to 17 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Guillain-Barré Syndrome, Miller Fisher Syndrome
Interventions: Not listed
Lead sponsor: Erasmus Medical Center; Other
Eligibility: Not listed
Enrollment: 2,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2024
U.S. locations: 26
States / cities: Phoenix, Arizona • Orange, California • New Haven, Connecticut + 19 more

Conditions: Schizophrenia
Interventions: PF 03654746, Placebo; Drug · Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 40 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Cardiac Arrhythmia
Interventions: Electrophysiology procedure; Device
Lead sponsor: CathVision ApS; Industry
Eligibility: 18 Years and older
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Electrophysiology Study, Ablation
Interventions: Peritorq; Device
Lead sponsor: University of Minnesota; Other
Eligibility: Up to 21 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: Washington D.C., District of Columbia • Minneapolis, Minnesota

Conditions: Speech, Memory, Delayed, Sensorineural Hearing Loss
Interventions: Sentence stimulus, Speaking style; Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 60 Years to 90 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Anesthesia
Interventions: No Intervention Used; Other
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Ventricular Tachycardia
Interventions: MRI guided VT ablation, Increased dose of amiodarone; Procedure · Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 99 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Atrial Flutter, Ventricular Tachycardia
Interventions: Amigo catheter robot; Device
Lead sponsor: Catheter Robotics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 181 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 11
States / cities: Newport Beach, California • Redwood City, California • Chicago, Illinois + 8 more

Conditions: LAMA2-MD (Merosin Deficient Congenital Muscular Dystrophy, MDC1A)
Interventions: Not listed
Lead sponsor: Cure CMD; Other
Eligibility: Not listed
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: San Pedro, California

Conditions: Ventricular Tachycardia, Cardiovascular Diseases, Arrythmia, CVD
Interventions: Not listed
Lead sponsor: CardioDx; Industry
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Hypertrophic Cardiomyopathy (HCM)
Interventions: Not listed
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: Up to 21 Years
Enrollment: 145 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Coronary Artery Disease, Electrophysiology, Cardiovascular Disease
Interventions: Not listed
Lead sponsor: Intermountain Health Care, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 30,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1994 – 2027
U.S. locations: 1
States / cities: Murray, Utah

Conditions: Cardiac Arrhythmia
Interventions: Oxytocin, Saline; Drug · Other
Lead sponsor: William Whang; Other
Eligibility: 18 Years to 85 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Aortic Stenosis, Heart Block, Aortic Insufficiency
Interventions: Electrophysiology Study; Diagnostic Test
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older
Enrollment: 126 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Sudden Cardiac Death
Interventions: Invasive Electrophysiology Study; Procedure
Lead sponsor: Western University, Canada; Other
Eligibility: Not listed
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2025
U.S. locations: 11
States / cities: Los Angeles, California • San Diego, California • San Francisco, California + 8 more

Conditions: Healthy Volunteer
Interventions: SAGE-718, Placebo; Drug
Lead sponsor: Supernus Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 2
States / cities: Long Beach, California • Berlin, New Jersey

Conditions: Atrial Fibrillation
Interventions: renal denervation, Catheter ablation; Device
Lead sponsor: Vivek Reddy; Other
Eligibility: 18 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 13
States / cities: Phoenix, Arizona • Jonesboro, Arkansas • Loma Linda, California + 9 more

Conditions: Healthy Volunteer
Interventions: SAGE-718, Placebo; Drug
Lead sponsor: Supernus Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 2
States / cities: Long Beach, California • Berlin, New Jersey

Conditions: Sentence Stimulus, Auditory Noise
Interventions: Sentence Stimulus, Auditory Noise; Other
Lead sponsor: University of Utah; Other
Eligibility: 60 Years to 90 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Atrial Fibrillation
Interventions: KODEX - EPD; Device
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Healthy Volunteer
Interventions: SAGE-904, Placebo, Ketamine; Drug
Lead sponsor: Supernus Pharmaceuticals, Inc.; Industry
Eligibility: 21 Years to 55 Years
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Newark, New Jersey

Search by objective public record fields.

Gait Adaptation Study

Biventricular Pacing in the Pediatric Population

Post Anesthesia Care Unit (PACU) Weighted Blanket Study

International Guillain-Barré Syndrome Outcome Study

Add On Treatment for Cognitive Deficits in Schizophrenia

An Evaluation of the Safety and Performance of the CathVision ECGenius® System.

Torque Device Evaluation

Effects of Clear Speech on Listening Effort and Memory in Sentence Processing

Anesthesia Charting Fidelity Study

Anti-arrhythmic Medication v. MRI-Merge Ablation in the Treatment of Ventricular Tachycardia

Clinical Study to Evaluate the Catheter Robotics Amigo for Performing Right-Sided Electrophysiology Mapping Studies

LAMA2-related Muscular Dystrophy Brain Study

Genetic Substudy of the Alternans Before Cardioverter Defibrillator (ABCD) Trial

Identification of Risk Factors for Arrhythmia in Children and Adolescents With Hypertrophic Cardiomyopathy

Database Registry of the Intermountain Heart Collaborative Study

Oxytocin Effects on Cardiac Electrophysiology

Conduction Disease After Transcatheter Aortic Valve Replacement

The Role of Electrophysiology Testing in Survivors of Unexplained Cardiac Arrest

A Study to Assess Electrophysiology, Safety, Tolerability, and Pharmacokinetics of Multiple Doses of SAGE-718 Using Ketamine Challenge in Healthy Subjects

Ultrasound-Based Renal Sympathetic Denervation as Adjunctive Upstream Therapy During Atrial Fibrillation Ablation

A Study to Assess the Electrophysiology, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Response Using Magnetic Resonance Imaging of SAGE-718 Using a Ketamine Challenge in Healthy Subjects

Effects of Listening Effort on Sentence Processing and Memory (Study 1)

All Inclusive Kodex - EPD Study

Study of SAGE-904 Using a Ketamine Challenge to Evaluate Electrophysiology, Safety, Tolerability, and Pharmacokinetics in Healthy Participants